Brief: Psyence Group Enters Into Debt-For-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical
14/10/2024 15:51
Oct 14 (Reuters) - PSYENCE GROUP INC:
* PSYENCE GROUP ENTERS INTO DEBT-FOR-EQUITY SWAP AGREEMENT
WITH
ITS NASDAQ-LISTED ASSOCIATE, PSYENCE BIOMEDICAL
* PSYENCE GROUP INC - PSYENCE BIOMED TO ISSUE 2.8 MILLION
SHARES
AT $0.50 EACH
((Reuters.Briefs@thomsonreuters.com))
Recent news on Psyence
See all newsBrief: Psyence Group To Consolidate Shares 15 To 1 Effective April 23, 2025
Brief: Psyence Group Enters Into Debt-For-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical
Brief: Psyence Biomed Enters Into Agreement To Acquire Stake In Psylabs
Brief: Psyence Biomedical Ltd. Approved To List On Nasdaq Following Completion Of Business Combination Agreement With Newcourt Acquisition Corp
MGC Pharmaceuticals - September 2023 Quarter Activity Report